Significance of changes in TNF-α and IL-10 levels in the progression of heart failure subsequent to myocardial infarction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 1, 2006, Pages

  Kaur, K ^b   Sharma, A K ^b   Singal, P K ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b NONE

Author keywords

Cardiac function; Congestive heart failure; Cytokines

Indexed keywords

INTERLEUKIN 10; LOSARTAN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE COURSE; DRUG INHIBITION; DRUG MECHANISM; ECHOCARDIOGRAPHY; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

ANIMALS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; INTERLEUKIN-10; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745698667     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01327.2005     Document Type: Article

References (43)

1. Adamopoulos S, Parissis JT, Paraskevaidis I, Karatzas D, Livanis E, Georgiadis M, Karavolias G, Mitropoulos D, Degiannis D, and Kremastinos DT. Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 24: 2186-2196, 2003.
2. Akassoglou K, Probert L, Kontogeorgos G, and Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 158: 438-445, 1997.
3. Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, Nordoy I, Aass H, Espevik T, Simonsen S, Froland SS, and Gullestad L. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83: 376-382, 1999.
4. Berthonneche C, Sulpice T, Boucher F, Gouraud L, de Leiris J, O'Connor SE, Herbert JM, and Janiak P. New insights into the pathological role of TNF-α in early cardiac dysfunction and subsequent heart failure after infarction in rats. Am J Physiol Heart Circ Physiol 287: H340-H350, 2004.
5. Bogdan C, Vodovotz Y, and Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 174: 1549-1555, 1991.
6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
7. Capsoni F, Minonzio F, Mariani C, Ongari AM, Bonara P, and Fiorelli G. Development of phagocytic function of cultured human monocytes is regulated by cell surface IL-10. Cell Immunol 189: 51-59, 1998.
8. Chung ES, Packer M, Lo KH, Fasanmade AA, and Willerson JT. Anti-TNF Therapy Against Congestive Heart Failure Investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107: 3133-3140, 2003.
9. Das UN. Is angiotensin II an endogenous pro-inflammatory molecule? Med Sci Monit 11: 155-162, 2005.
10. Diwan A, Dibbs Z, Nemoto S, DeFreitas G, Carabello BA, Sivasubramanian N, Wilson EM, Spinale FG, and Mann DL. Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. Circulation 109: 262-268, 2004.
11. Dixon IM, Hata T, and Dhalla NS. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol Heart Circ Physiol 262: H1387-H1394, 1992.
12. Driessler F, Venstrom K, Sabat R, Asadullah K, and Schottelius AJ. Molecular mechanisms of interleukin-10-mediated inhibition of NF-κB activity: a role for p50. Clin Exp Immunol 135: 64-73, 2004.
13. El Azab SR, Rosseel PM, de Lange JJ, Groeneveld AB, van Strik R, van Wijk EM, and Scheffer GJ. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth 88: 496-501, 2002.
14. Fiorentino DF, Bond MW, and Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081-2095, 1989.
15. Fishbein MC, Maclean D, and Maroko PR. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90: 57-70, 1978.
16. Francis J, Chu Y, Johnson AK, Weiss RM, and Felder RB. Acute myocardial infarction induces hypothalamic cytokine synthesis. Am J Physiol Heart Circ Physiol 286: H2264-H2271, 2004.
17. Francis J, Zhang ZH, Weiss RM, and Felder RB. Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am J Physiol Heart Circ Physiol 287: H791-H797, 2004.
18. George J, Biner S, Keren P, Barshack I, Goldberg I, Sherez J, Levitzki A, Keren G, and Roth A. Tyrphostin AG-556 reduces myocardial infarct size and improves cardiac performance in the rat. Exp Mol Pathol 74: 314-318, 2003.
19. Georgopoulos S, Plows D, and Kollias G. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 46: 86-97, 1996.
20. Giomarelli P, Scolletta S, Borrelli E, and Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg 76: 117-123, 2003.
21. Gullestad L, Ueland T, Brunsvig A, Kjekshus J, Simonsen S, Froland SS, and Aukrust P. Effect of metoprolol on cytokine levels in chronic heart failure - a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF). Am Heart J 141: 418-421, 2001.
22. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen WH, Shou Z, and Liu P. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 99: 1492-1498, 1999.
23. Khaper N and Singal PK. Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats. J Am Coll Cardiol 37: 1461-1466, 2001.
24. Küsters S, Tiegs G, Alexopoulou L, Pasparakis M, Douni E, Künstle G, Bluethmann H, Wendel A, Pfizenmaier K, Kollias G, and Grell M. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol 27: 2870-2875, 1997.
25. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, and Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96: 2304-2310, 1995.
26. Lentsch AB, Shanley TP, Sarma V, and Ward PA. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J Clin Invest 100: 2443-2448, 1997.
27. Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, and Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 19: 611-616, 1999.
28. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, and Fleming T. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109: 1594-1602, 2004.
29. Mazzone A, De Servi S, Vezzoli M, Fossati G, Mazzucchelli I, Gritti D, Ottini E, Mussini A, and Specchia G. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 145: 369-374, 1999.
30. Medvedev AE, Espevik T, Ranges G, and Sundan A. Distinct roles of the two tumor necrosis factor (TNF) receptors in modulating TNF and lymphotoxin effects. J Biol Chem 271: 9978-9984, 1996.
31. Milavetz JJ, Raya TE, Johnson CS, Morkin E, and Goldman S. Survival after myocardial infarction in rats: captopril versus losartan. J Am Coll Cardiol 27: 714-719, 1996.
32. Moore KW, de Waal Malefyt R, Coffman RL, and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765, 2001.
33. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, and Ward PA. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 151: 5666-5674, 1993.
34. Ono K, Matsumori A, Shioi T, Furukawa Y, and Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98: 149-156, 1998.
35. Schottelius AJ, Mayo MW, Sartor RB, and Baldwin AS Jr. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. J Biol Chem 274: 31868-31874, 1999.
36. Shames BD, Barton HH, Reznikov LL, Cairns CB, Banerjee A, Harken AH, and Meng X. Ischemia alone is sufficient to induce TNF-α mRNA and peptide in the myocardium. Shock 17: 114-119, 2002.
37. Shanley TP, Schmal H, Friedl HP, Jones ML, and Ward PA. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol 154: 3454-3460, 1995.
38. Stumpf C, Lehner C, Yilmaz A, Daniel WG, and Garlichs CD. Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure. Clin Sci (Lond) 105: 45-50, 2003.
39. Torre-Amione G, Stetson SJ, Youker KA, Durand JB, Radovancevic B, Delgado RM, Frazier OH, Entman ML, and Noon GP. Decreased expression of tumor necrosis factor-α in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100: 1189-1193, 1999.
40. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 95: 3C-8C, 2005.
41. Ukimura A, Terasaki F, Fujioka S, Deguchi H, Kitaura Y, Isomura T, and Suma H. Quantitative analysis of cytokine mRNA expression in hearts from patients with nonischemic dilated cardiomyopathy (DCM). J Card Surg Suppl 2: S101-S108, 2003.
42. Waehre T, Halvorsen B, Damas JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Froland SS, and Aukrust P. Inflammatory imbalance between IL-10 and TNFα in unstable angina: potential plaque stabilizing effects of IL-10. Eur J Clin Invest 32: 803-810, 2002.
43. Zimmerman MA, Reznikov LL, Raeburn CD, and Selzman CH. Interleukin-10 attenuates the response to vascular injury. J Surg Res 121: 206-213, 2004.